Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (701)	3/16/1999 10:00:00 AM
From: scaram(o)uche	Respond to of 1073

>> Does anyone have a short list of companies with the promise of producing "large quantities of angiostatin and endostatin". << Jeffrey: I've lost track of contract production capacity. XOMA is working a project for GNE, but that was a timing issue in addition to capacity issues. Perhaps you could ask in that thread. Let's stick to companies with a low Market cap to book ratio in this thread..... MBIO (GMED) certainly qualifies, but ENMD is way off-topic. Re. other companies looking at gene therapy with IFN.... nope, I don't know of any..... ask in the BGEN thread? Thanks for the reference to angio, I didn't know about that connection for IFNalpha. And, I'm certain that many here would appreciate more discussion of GMED/MBIO. Rick